Cargando…

More Efficient Complement Activation by Anti–Aquaporin-4 Compared With Anti–Myelin Oligodendrocyte Glycoprotein Antibodies

BACKGROUND AND OBJECTIVES: The objective was to study complement-mediated cytotoxicity induced by immunoglobulin G (IgG) anti–aquaporin-4 antibodies (AQP4-IgG) and anti–myelin oligodendrocyte glycoprotein antibodies (MOG-IgG) in human serum samples from patients suffering from the rare demyelinating...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lerch, Magdalena, Schanda, Kathrin, Lafon, Eliott, Würzner, Reinhard, Mariotto, Sara, Dinoto, Alessandro, Wendel, Eva Maria, Lechner, Christian, Hegen, Harald, Rostásy, Kevin, Berger, Thomas, Wilflingseder, Doris, Höftberger, Romana, Reindl, Markus
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9682624/ https://www.ncbi.nlm.nih.gov/pubmed/36414427 http://dx.doi.org/10.1212/NXI.0000000000200059

Ejemplares similares

Increased peripheral inflammatory responses in myelin oligodendrocyte glycoprotein associated disease and aquaporin-4 antibody positive neuromyelitis optica spectrum disorder
por: Bauer, Angelika, et al.
Publicado: (2022)

Comparative Analysis of T-Cell Responses to Aquaporin-4 and Myelin Oligodendrocyte Glycoprotein in Inflammatory Demyelinating Central Nervous System Diseases
por: Hofer, Livia Sophie, et al.
Publicado: (2020)

Human antibodies against the myelin oligodendrocyte glycoprotein can cause complement-dependent demyelination
por: Peschl, Patrick, et al.
Publicado: (2017)

Serum Neurofilament Light Chain in NMOSD and Related Disorders: Comparison According to Aquaporin-4 and Myelin Oligodendrocyte Glycoprotein Antibodies Status
por: S, Mariotto, et al.
Publicado: (2017)

Myelin Oligodendrocyte Glycoprotein: Deciphering a Target in Inflammatory Demyelinating Diseases
por: Peschl, Patrick, et al.
Publicado: (2017)

Complement activating antibodies to myelin oligodendrocyte glycoprotein in neuromyelitis optica and related disorders
por: Mader, Simone, et al.
Publicado: (2011)

The Potential Pathogenicity of Myelin Oligodendrocyte Glycoprotein Antibodies in the Optic Pathway
por: Lerch, Magdalena, et al.
Publicado: (2023)

Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease and Varicella Zoster Virus Infection - Frequency of an Association
por: Di Pauli, Franziska, et al.
Publicado: (2021)

Diagnostic challenges and pitfalls of myelin oligodendrocyte glycoprotein antibody–associated demyelination: Lessons from neuropathology
por: Höftberger, Romana, et al.
Publicado: (2019)

Impaired Brain Growth in Myelin Oligodendrocyte Glycoprotein Antibody–Associated Acute Disseminated Encephalomyelitis
por: Bartels, Frederik, et al.
Publicado: (2023)

Serum and Cerebrospinal Fluid Biomarkers in Neuromyelitis Optica Spectrum Disorder and Myelin Oligodendrocyte Glycoprotein Associated Disease
por: Dinoto, Alessandro, et al.
Publicado: (2022)

Limbic Encephalitis with Anti-myelin Oligodendrocyte Glycoprotein Antibody
por: Takasone, Ken, et al.
Publicado: (2020)

Cerebrospinal fluid findings in patients with myelin oligodendrocyte glycoprotein (MOG) antibodies. Part 1: Results from 163 lumbar punctures in 100 adult patients
por: Jarius, Sven, et al.
Publicado: (2020)

Clinical spectrum and IgG subclass analysis of anti-myelin oligodendrocyte glycoprotein antibody-associated syndromes: a multicenter study
por: Mariotto, Sara, et al.
Publicado: (2017)

Gray Matter Encephalomyelitis with Anti-Myelin Oligodendrocyte Glycoprotein Antibody
por: Morizumi, Teruya, et al.
Publicado: (2020)

Seroprevalence of anti‐myelin oligodendrocyte glycoprotein antibodies in adults with myelitis
por: Kim, Ki Hoon, et al.
Publicado: (2022)

Cerebrospinal fluid findings in patients with myelin oligodendrocyte glycoprotein (MOG) antibodies. Part 2: Results from 108 lumbar punctures in 80 pediatric patients
por: Jarius, Sven, et al.
Publicado: (2020)

Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD): A Review of Clinical and MRI Features, Diagnosis, and Management
por: Sechi, Elia, et al.
Publicado: (2022)

Beyond Myelin Oligodendrocyte Glycoprotein and Aquaporin-4 Antibodies: Alternative Causes of Optic Neuritis
por: Greco, Giacomo, et al.
Publicado: (2023)

CNS Demyelinating Attacks Requiring Ventilatory Support With Myelin Oligodendrocyte Glycoprotein or Aquaporin-4 Antibodies
por: Zhao-Fleming, Hannah H., et al.
Publicado: (2021)

Intractable Hiccup in Demyelinating Disease with Anti-Myelin Oligodendrocyte Glycoprotein (MOG) Antibody
por: Akaishi, Tetsuya, et al.
Publicado: (2016)

White blood cell count profiles in anti-aquaporin-4 antibody seropositive neuromyelitis optica spectrum disorder and anti-myelin oligodendrocyte glycoprotein antibody-associated disease
por: Akaishi, Tetsuya, et al.
Publicado: (2023)

Different Characteristics of Aquaporin-4 and Myelin Oligodendrocyte Glycoprotein Antibody-Seropositive Male Optic Neuritis in China
por: Song, Honglu, et al.
Publicado: (2019)

Testing for Antibodies Against Aquaporin-4 and Myelin Oligodendrocyte Glycoprotein in the Diagnosis of Patients With Suspected Autoimmune Myelopathy
por: Alkabie, Samir, et al.
Publicado: (2022)

The pathology of central nervous system inflammatory demyelinating disease accompanying myelin oligodendrocyte glycoprotein autoantibody
por: Höftberger, Romana, et al.
Publicado: (2020)

Frequency of myelin oligodendrocyte glycoprotein antibodies in a large cohort of neurological patients
por: Held, Friederike, et al.
Publicado: (2021)

The Relationship between Anti-Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease and the Rubella Virus
por: Choi, Seok-Jin, et al.
Publicado: (2018)

Serial Anti–Myelin Oligodendrocyte Glycoprotein Antibody Analyses and Outcomes in Children With Demyelinating Syndromes
por: Waters, Patrick, et al.
Publicado: (2019)

Aseptic Meningitis as an Initial Manifestation of Anti-myelin Oligodendrocyte Glycoprotein Antibody-associated Disease
por: Suzuki, Takehiro, et al.
Publicado: (2019)

Relapse activity in the chronic phase of anti-myelin-oligodendrocyte glycoprotein antibody-associated disease
por: Akaishi, Tetsuya, et al.
Publicado: (2021)

Anti-myelin Oligodendrocyte Glycoprotein Antibody-positive Myelitis after Coronavirus Disease 2019
por: Uchino, Kenji, et al.
Publicado: (2023)

Decreased Frequency of Circulating Myelin Oligodendrocyte Glycoprotein B Lymphocytes in Patients with Relapsing-Remitting Multiple Sclerosis
por: Elong Ngono, Annie, et al.
Publicado: (2015)

Isolated Double-Positive Optic Neuritis: A Case of Aquaporin-4 and Myelin Oligodendrocyte Glycoprotein Antibody Seropositivity
por: Mason, Matthew C, et al.
Publicado: (2021)

Guilty by association? SARS‐CoV‐2 antibodies and myelin oligodendrocyte glycoprotein antibody‐associated disease
por: Tanasescu, Radu, et al.
Publicado: (2022)

Pathophysiology of myelin oligodendrocyte glycoprotein antibody disease
por: Corbali, Osman, et al.
Publicado: (2023)

Anti-myelin oligodendrocyte glycoprotein antibody-positive coursing with optic neuritis: Imaging and clinical implications
por: Thatikonda, Nithisha, et al.
Publicado: (2020)

Epilepsia Partialis Continua as an Early Sign of Anti-Myelin Oligodendrocyte Glycoprotein Antibody-positive Encephalitis
por: Katsuse, Kazuto, et al.
Publicado: (2020)

Tozinameran: Anti-myelin oligodendrocyte glycoprotein antibody-positive acute disseminated encephalomyelitis: case report
Publicado: (2022)

A case of unilateral recurrent cerebral cortical encephalitis with anti-myelin oligodendrocyte glycoprotein antibodies
por: Guo, Liying, et al.
Publicado: (2022)

Characterization of the human myelin oligodendrocyte glycoprotein antibody response in demyelination
por: Tea, Fiona, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_iuqffogfl7t2kq02f9c90u6ln2